// App-Quantinova.ai

TH-OR08 : Regional Variation of Erythropoietin-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

Researchers

Presenter

  • Singh AjayK

Principal Investigators

  • Blackorby Allison

  • Cizman Borut

  • Cobitz AlexanderRalph

  • Godoy SergioAriel

  • Jha Vivekanand

  • Johansen KirstenL

  • McMahon GearoidM

  • Meadowcroft AmyM

  • Obrador GregorioT

  • Wong Muh Geot

  • Macdougall IainC

Medical Centers

  • Brigham and Womens Hospital, Brookline, Massachusetts, United States

  • GlaxoSmithKline Research Triangle North Carolina United States

  • GSK, Collegeville, Pennsylvania, United States

  • George Clinical Pilar Argentina

  • The George Institute for Global Health, Sydney, NewSouth Wales, Australia

  • Hennepin Healthcare, Minneapolis, MN, United States

  • Universidad Panamericana., Mexico City, Mexico

  • Royal Northshore Hospital, St Leonards, New South Wales, Australia

  • King's College Hospital- London, Pediatrics, London, United Kingdom

Locations

  • United States

  • Argentina

  • Australia

  • Mexico

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • Erythropoietin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved